The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Landore Leaps On Canadian Gold Discovery

Mon, 04th Apr 2016 09:41

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.
----------
FTSE 100 - WINNERS
----------
International Consolidates Airlines Group, up 1.8% at 562.08 pence. Liberum raises its price target on the British Airways parent by 25% to 875p from 700p. Liberum analyst Gerald Khoo said he sees "considerable scope for a re-rating" in the shares. The analyst said there is "a growing disconnect between the fundamentals and valuation of IAG" as "a record performance has been met by a de-rating of the shares". In February, IAG reported a more than doubling in profit in 2015, as revenue grew despite taking a small hit to sales in the fourth quarter following the terrorist attacks in Paris.

Centrica, up 1.7%. The British Gas parent is in early talks over a tie-up with the oil and gas production arm of Engie, the French state-backed energy giant, the Sunday Times reported without saying where it got the information. The report said that Centrica is "understood" to have hired investment bank JP Morgan for advice. Engie and Centrica co-own Cygnus, one of the largest gas fields in the North Sea. "A combination with Engie’s oil and gas arm, perhaps under a new joint venture vehicle, would allow both companies to reduce costs by cutting overlap and extracting better terms from suppliers. It is unclear whether a deal will be struck," the report said.

Anglo American, up 1.5%. The miner has agreed to sell its 70% stake in the Foxleigh metallurgical coal mine in Queensland, Australia. No financial details on the sale were disclosed, but Anglo said it has sold the stake to a consortium led by Taurus Fund Management. Foxleigh is an open-cut coal mine which produces high-quality pulverised coal injection coal, Anglo said. It is located in the Bowen Basin in Queensland and delivered 1.86 million tonnes of production attributable to Anglo in 2015.
----------
FTSE 100 - LOSERS
----------
Mondi, down 2.7%. The Anglo-South African paper and packaging company said Russian authorities have started an investigation into its Russian business. Mondi said the Federal Antimonopoly Service of the Russian Federation said last week it had initiated an investigation into Mondi Syktyvkar for violating anti-monopoly laws in regards to pricing of offset paper. On Friday, the Federal Antimonopoly Service said it had opened a case against Mondi's unit in the country. It said it had established the cost of offset paper for domestic customers had increased around 50%, which did not match the change in the cost of producing and selling the goods.
----------
FTSE 250 - WINNERS
----------
Brewin Dolphin Holdings, up 1.6%. N+1 Singer upgraded the wealth manager to Buy from Hold.
---------
MAIN MARKET AND AIM - WINNERS
----------
Landore Resources, up 189%. The miner said it has made a significant gold discovery at the Junior Lake project in Ontario, Canada. Landore said follow-up drilling on the BAM East gold prospect at the project has established the presence of a significant gold discovery at the site, with gold mineralisation open along the east and west of the site. Intersections of up to 5.74 grams per tonne of gold were seen in the drill holes, Landore said, adding current drilling indicates mineralisation may be increasing with depth.

LiDCO Group, up 12%. The medical monitoring products maker said the US Food & Drug Administration granted 510k market clearance for its latest product, the LiDCOunity, a hemodynamic monitor that combines the company's technology into one platform. The company said the approval was "key" to ensure it is able to offer its latest technology to surgeons and anaesthetists.

Chemring Group, up 8.9%. The defence contractor said the implementation of its ammunition contract with a customer in the Middle East has started, with a letter of credit in place and an advance payment now received. Chemring said in-house and supply-chain production has started on the contract, with initial revenue to be recognised in the second quarter of its current financial year to the end of October. Chemring expects the deal to make a significant contribution to its results in the 2016 financial year.
----------
MAIN MARKET AND AIM - LOSERS
----------
Caza Oil & Gas, off 49% at 0.291p. The oil and gas company said has received a proposal from its majority shareholder to take the company private and cancel its listing on AIM. Caza said Talara Opportunities V LP, which already owns 95% of Caza's shares, has made a proposed to take the company private at a cash price of USD0.00481 per share, equivalent to about 0.34 pence. The price is around 12% higher than the valuation placed on the company by an independent committee of Caza directors, Caza said. Caza will hold a meeting on the proposals on April 29 and expects its AIM listing to be cancelled by May 10. The company also intends to voluntarily de-list from the Toronto Stock Exchange.

Sepura, down 28%. The critical communications provider said its earnings before interest, tax, depreciation and amortisation in its recently ended financial year will be lower than expected. The company said said its adjusted Ebitda for the year ended April 1 will be between EUR16 million and EUR20 million, missing expectations for the year. It said this was due to two significant orders being delayed into the first quarter of the new financial year, as well as a EUR2.6 million hit from adverse foreign exchange rates.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
6 Jun 2014 05:24

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Friday, June 6
Read more
5 Jun 2014 15:08

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Friday, June 6
Read more
5 Jun 2014 05:10

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Thursday, June 5
Read more
4 Jun 2014 15:29

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Thursday, June 5
Read more
21 May 2014 12:55

NantHealth completes communications link with LiDCO

AIM-listed medical group LiDCO announced US-based healthcare firm NantHealth has developed a communications link between LiDCO's blood analysis monitors and its DeviceConX system. NantHealth's software, DeviceConx, collects and transmits data from medical devices into an electronic record for docto

Read more
21 May 2014 11:48

LiDCO Group Monitors Link With NantHealth's Software System

LONDON (Alliance News) - LiDCO Group PLC said Wednesday said US-based NantHealth has successfully completed development of a proprietary communications link between LiDCO monitors and its own DeviceConX system. NantHealth's DeviceConX is a software solution that collects and transmits data

Read more
20 May 2014 14:56

LiDCO Says Results Of Study Using Its Cardiac Monitor Published

LONDON (Alliance News) - LiDCO Group PLC Tuesday said a recent study published in the Journal of American Medical Association found that perioperative hemodynamic intervention is associated with a reduced complication rate and length of stay in hospital after surgery. A test was conducted i

Read more
1 May 2014 10:53

LiDCO Says Study Supports Its Monitors For Post Surgery Programmes

LONDON (Alliance News) - LiDCO Group PLC Thursday noted a study that it said showed that an enhanced recovery after surgery programme using its haemodynamic monitors reduced length of hospital stay and incidences of urinary tract infections. The study, by the Enhanced Recovery Study Group a

Read more
29 Apr 2014 12:40

LiDCO Swings To Profit As Revenue Boosted By Strong UK Performance

LONDON (Alliance News) - LiDCO PLC Tuesday expressed confidence for 2014 after it swung to a pretax profit for 2013, as revenue was boosted by strong growth from its UK business. LiDCO produces cardiac monitoring equipment and disposables. LiDCO posted a pretax profit of GBP217,000, s

Read more
17 Mar 2014 13:11

LiDCO To Launch New Version Of LiDCOrapid Software

LONDON (Alliance News) - LiDCO Group PLC said Monday that it will be launching a new version of its LiDCOrapidv2 software at the International Symposium on Intensive Care and Emergency Medicine in Brussels. The conference, organised by the department of Intensive Care Emergency Medicine of

Read more
17 Mar 2014 12:49

CORRECT: UK MIDDAY BRIEFING: Housebuilders Lead FTSE 350 On More Help-To-Buy

(Correcting direction of FTSE 250 index.) LONDON (Alliance News) - Housebuilders lead a surprisingly upbeat UK equities market Monday, occupying six of the top ten spaces in the FTSE 350, buoyed by an extension to the UK government's Help to Buy scheme.

Chancellor George Osbor

Read more
17 Mar 2014 12:45

UK MIDDAY BRIEFING: Housebuilders Lead FTSE 350 On More Help-To-Buy

LONDON (Alliance News) - Housebuilders lead a surprisingly upbeat UK equities market Monday, occupying six of the top ten spaces in the FTSE 350, buoyed by an extension to the UK government's Help to Buy scheme.

Chancellor George Osborne confirmed that the government's flagship Help

Read more
17 Mar 2014 11:57

UK WINNERS & LOSERS: Housebuilders Jump; Supermarkets Fall Again

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Persimmon, up 4.7%. The housebuilder's share price has jumped following c

Read more
12 Mar 2014 15:45

Medical research boosts LiDCO hopes

An independent medical study proving the cost-effectiveness of monitoring bloodflow during surgery has been welcomed by AIM-listed LiDCO, whose equipment was used for the trials. Published data examining the cost effectiveness of post-operative goal-directed therapy (GDT), a surgical intervention t

Read more
12 Mar 2014 10:17

Study Supports LiDCO's Monitoring Equipment For Postoperative Therapy

LONDON (Alliance News) - LiDCO Group PLC said Wednesday that a study into the cost-effectiveness of Postoperative Goal-Directed Therapy proved that this type of care was both cost and clinically effective, supporting the use of its LiDCOplus monitoring equipment. The LiDCOplus monitor provi

Read more

Quickpicks are a member only feature

Login to your account